Physician profile
Christopher James Yanichko
NPI 1366904310
$1,737.68
in general payments reported to CMS, 2019-2025
10 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2022: $104 · 2023: $603 · 2024: $769 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $614.94 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $225.71 | 2022-2024 | Farxiga |
| Gilead Sciences, INC. | $146.94 | 2024 | Veklury |
| Mallinckrodt Hospital Products INC. | $146.63 | 2025 | Terlivaz |
| Inari Medical, INC. | $119.85 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lexicon Pharmaceuticals, INC. | $117.39 | 2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.25 | 2019 | |
| Intuity Medical INC | $99.10 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.40 | 2023 | Lifevest |
| Pfizer INC. | $56.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Yanichko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.